Search

everythinglearnresearchcommunity

for

Search:↓

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Finasteride improves hair loss in women with hyperandrogenism.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Finasteride reduces alcohol withdrawal severity in male mice but increases it in female mice.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Oral retinoids may help some patients with hard-to-treat lichen planopilaris, but more research is needed.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Some herbal treatments are effective for skin disorders, but more research and regulation are needed.